Mariner, LLC Novartis Ag Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Novartis Ag stock. As of the latest transaction made, Mariner, LLC holds 203,048 shares of NVS stock, worth $20.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

203,048

Previous 197,781 2.66%

Holding current value

$20.1 Million

Previous $21.1 Million 10.92%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$106.13 - $120.89 $558,986 - $636,727	5,267 Added 2.66%	203,048 $23.4 Million
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $496,082 - $575,395	5,359 Added 2.79%	197,781 $21.1 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $78,121 - $88,945	820 Added 0.43%	192,422 $18.6 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $171,160 - $188,356	1,855 Added 0.98%	191,602 $19.3 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $349,932 - $388,350	3,694 Added 1.99%	189,747 $19.3 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $467,411 - $530,005	-5,052 Reduced 2.64%	186,053 $18.8 Million
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $225,604 - $261,631	-2,819 Reduced 1.45%	191,105 $17.6 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $116,951 - $143,220	1,548 Added 0.8%	193,924 $17.6 Million
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $2.34 Million - $2.74 Million	31,377 Added 19.49%	192,376 $14.6 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $397,446 - $462,750	4,936 Added 3.16%	160,999 $13.6 Million
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $357,530 - $404,437	4,463 Added 2.94%	156,063 $13.7 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $1.97 Million - $2.18 Million	24,750 Added 19.51%	151,600 $13.3 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $6.06 Million - $7.05 Million	74,123 Added 140.58%	126,850 $10.4 Million
Q2 2021 Aug 24, 2021	BUY	$85.24 - $94.15 $258,959 - $286,027	3,038 Added 6.11%	52,727 $4.81 Million
Q1 2021 May 07, 2021	BUY	$83.5 - $98.47 $379,340 - $447,349	4,543 Added 10.06%	49,689 $4.25 Million
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $665,702 - $805,204	8,527 Added 23.29%	45,146 $4.26 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $106,946 - $118,482	-1,302 Reduced 3.43%	36,619 $3.18 Million
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $246,350 - $277,308	3,044 Added 8.73%	37,921 $3.31 Million
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $529,247 - $741,485	7,489 Added 27.34%	34,877 $2.88 Million
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $62,925 - $71,146	-746 Reduced 2.65%	27,388 $2.59 Million
Q3 2019 Nov 13, 2019	BUY	$85.54 - $94.26 $222,489 - $245,170	2,601 Added 10.19%	28,134 $2.45 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $338,998 - $417,228	4,496 Added 21.37%	25,533 $2.33 Million
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $551,643 - $630,962	7,324 Added 53.41%	21,037 $2.02 Million
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $13,774 - $15,337	-187 Reduced 1.35%	13,713 $1.18 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $191,916 - $221,991	2,867 Added 25.99%	13,900 $1.2 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $345,386 - $390,348	5,321 Added 93.15%	11,033 $833,000
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $402,067 - $480,664	5,712 New	5,712 $462,000
Q4 2017 Feb 09, 2018	SELL	$72.33 - $77.64 $225,597 - $242,159	-3,119 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $231,242 - $241,005	3,119	3,119 $268,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $213B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account